2019;565:234–9. 9. Fang Y, Mo F, Shou J, Wang H, Luo K, Zhang S, et al. A pan-cancer clinical study of personalized neoantigen vaccine monotherapy in treating patients with various types of advanced solid tumors. Clin Cancer Res. 2020;26:4511–20. 10. Zeng Y, Zhang W, Li Z, Zheng Y, Wang Y, Chen G, et al. Personalized neo - antigen-based immunotherapy for advanced collecting duct carcinoma: case report. J Immunother Cancer. 2020;8:e000217. 11. Löffler MW, Mohr C, Bichmann L, Freudenmann LK, Walzer M, Schroeder CM, et al. Multi-omics discovery of exome-derived neoantigens in hepa- tocellular carcinoma. Genome Med. 2019;11:1–16. 12. Schulze K, Imbeaud S, Letouzé E, Alexandrov LB, Calderaro J, Rebouis- sou S, et al. Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets. Nat Genet.